A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours
Clinical trial NCT03427073 · TERMINATED
Trial details
- NCT number
- NCT03427073
- Sponsor
- Almac Discovery
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-27
- Primary completion
- 2017-03-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.